Peter J. Little

20 Cornwall St
Woolloongabba, QLD 4102, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 137 publications

Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axis.

Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axis.

Journal: Science bulletin

Published: October 28, 2025

Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases.

Emerging Roles of GDF15 in Metabolic and Cardiovascular Diseases.

Journal: Research (Washington, D.C.)

Published: June 11, 2025

Correction: Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway.

Correction: Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway.

Journal: Acta pharmacologica Sinica

Published: April 22, 2025

The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21.

The clinical antiprotozoal drug halofuginone promotes weight loss by elevating GDF15 and FGF21.

Journal: Science advances

Published: March 26, 2025

Targeting mitochondrial DNA-STING-NF-κB Axis-mediated microglia activation by cryptotanshinone alleviates ischemic retinopathy.

Targeting mitochondrial DNA-STING-NF-κB Axis-mediated microglia activation by cryptotanshinone alleviates ischemic retinopathy.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: October 09, 2024

Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE -/- mice.

Aclysiran, an RNAi therapeutic agent targeting ACLY, treats hypercholesterolemia and atherosclerosis in ApoE -/- mice.

Journal: Acta pharmaceutica Sinica. B

Published: July 18, 2024

Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling.

Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling.

Journal: Acta pharmacologica Sinica

Published: July 09, 2024

Anthocyanins in Vascular Health and Disease: Mechanisms of Action and Therapeutic Potential.

Anthocyanins in Vascular Health and Disease: Mechanisms of Action and Therapeutic Potential.

Journal: Journal of cardiovascular pharmacology

Published: April 12, 2024

Targeting the smooth muscle cell KEAP1-Nrf2-STING axis with pterostilbene attenuates abdominal aortic aneurysm.

Targeting the smooth muscle cell KEAP1-Nrf2-STING axis with pterostilbene attenuates abdominal aortic aneurysm.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: December 21, 2023

A novel mouse model of familial combined hyperlipidemia and atherosclerosis.

A novel mouse model of familial combined hyperlipidemia and atherosclerosis.

Journal: Acta pharmacologica Sinica

Published: December 05, 2023

A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection.

A proteome-wide screen identifies the calcium binding proteins, S100A8/S100A9, as clinically relevant therapeutic targets in aortic dissection.

Journal: Pharmacological research

Published: November 09, 2023

Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway.

Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathway.

Journal: Acta pharmacologica Sinica

Published: October 24, 2023

Showing 1-12 of 137

Last Updated: 09/26/2026